Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures

IMPORTANCE: Antiseizure medication (ASM) treatment duration for acute symptomatic neonatal seizures is variable. A randomized clinical trial of phenobarbital compared with placebo after resolution of acute symptomatic seizures closed early owing to low enrollment. OBJECTIVE: To assess whether ASM di...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:JAMA Neurol
Päätekijät: Glass, Hannah C., Soul, Janet S., Chang, Taeun, Wusthoff, Courtney J., Chu, Catherine J., Massey, Shavonne L., Abend, Nicholas S., Lemmon, Monica, Thomas, Cameron, Numis, Adam L., Guillet, Ronnie, Sturza, Julie, McNamara, Nancy A., Rogers, Elizabeth E., Franck, Linda S., McCulloch, Charles E., Shellhaas, Renée A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Medical Association 2021
Aiheet:
Original Investigation
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8145161/
https://ncbi.nlm.nih.gov/pubmed/34028496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2021.1437
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia